Sitera Pharmaceuticals Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $583K

  • Investors
  • 2

Sitera Pharmaceuticals General Information

Description

Developer of small molecule therapeutics intended to address rare and less rare neurodegenerative diseases with urgent patient needs. The company uses a proprietary technological platform that combines chemical and biological expertise to design powerful, selective, and safe drug candidates, focuses on providing clinical solutions for patients who have reached a therapeutic impasse, and targets challenging central nervous system conditions where existing treatment options are limited, enabling healthcare providers to potentially improve life conditions for affected patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Office 3
  • 6 B Boulevard Berthelot
  • 34000 Montpellier
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Office 3
  • 6 B Boulevard Berthelot
  • 34000 Montpellier
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sitera Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 22-Dec-2025 $583K Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2025 Completed Startup
To view Sitera Pharmaceuticals’s complete valuation and funding history, request access »

Sitera Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sitera Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Rare Diseases Research Alliance Impact Investing Minority
SATT AxLR Accelerator/Incubator
To view Sitera Pharmaceuticals’s complete investors history, request access »

Sitera Pharmaceuticals FAQs

  • When was Sitera Pharmaceuticals founded?

    Sitera Pharmaceuticals was founded in 2025.

  • Where is Sitera Pharmaceuticals headquartered?

    Sitera Pharmaceuticals is headquartered in Montpellier, France.

  • What is the size of Sitera Pharmaceuticals?

    Sitera Pharmaceuticals has 2 total employees.

  • What industry is Sitera Pharmaceuticals in?

    Sitera Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Sitera Pharmaceuticals a private or public company?

    Sitera Pharmaceuticals is a Private company.

  • What is the current valuation of Sitera Pharmaceuticals?

    The current valuation of Sitera Pharmaceuticals is .

  • What is Sitera Pharmaceuticals’s current revenue?

    The current revenue for Sitera Pharmaceuticals is .

  • How much funding has Sitera Pharmaceuticals raised over time?

    Sitera Pharmaceuticals has raised $1.68M.

  • Who are Sitera Pharmaceuticals’s investors?

    European Rare Diseases Research Alliance and SATT AxLR have invested in Sitera Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process